Our Vision
Improving the Outcomes and Quality of Life of Newborns at Risk
ELGAN Pharma is a late-stage neonatology-focused biotech company, dedicated to developing therapies for preterm infants.
Our therapies are safe and non-invasive, addressing high unmet medical needs for which there are no approved solutions to date.